FGF6 Gene

Migration, Crosslink

📖

FGF6 Gene

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-fgf6

📖 Wiki Page

gene2307 wordssynced 2026-04-02

FGF6 — Fibroblast Growth Factor 6

Overview

FGF6 (Fibroblast Growth Factor 6) is a member of the fibroblast growth factor family of signaling proteins that play critical roles in development, tissue repair, and cellular homeostasis. While initially characterized for its role in muscle regeneration and myogenesis, emerging research suggests potential functions in neural development and neuroprotection that may be relevant to understanding neurodegenerative disease mechanisms. This page provides a comprehensive overview of FGF6 gene structure, protein function, expression patterns, signaling pathways, and therapeutic implications for Alzheimer's Disease ([AD](/diseases/alzheimers-disease)) and Parkinson's Disease ([PD](/diseases/parkinsons-disease)).

...

FGF6 — Fibroblast Growth Factor 6

Overview

FGF6 (Fibroblast Growth Factor 6) is a member of the fibroblast growth factor family of signaling proteins that play critical roles in development, tissue repair, and cellular homeostasis. While initially characterized for its role in muscle regeneration and myogenesis, emerging research suggests potential functions in neural development and neuroprotection that may be relevant to understanding neurodegenerative disease mechanisms. This page provides a comprehensive overview of FGF6 gene structure, protein function, expression patterns, signaling pathways, and therapeutic implications for Alzheimer's Disease ([AD](/diseases/alzheimers-disease)) and Parkinson's Disease ([PD](/diseases/parkinsons-disease)).

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Fibroblast Growth Factor 6 (FGF6)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FGF6</td></tr>
<tr><td><strong>Full Name</strong></td><td>Fibroblast Growth Factor 6</td></tr>
<tr><td><strong>Chromosome</strong></td><td>12p13.32</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[2251](https://www.ncbi.nlm.nih.gov/gene/2251)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[134921](https://omim.org/entry/134921)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000140391</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P38467](https://www.uniprot.org/uniprot/P38467)</td></tr>
<tr><td><strong>Gene Type</strong></td><td>Protein coding</td></tr>
<tr><td><strong>Protein Length</strong></td><td>208 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~24 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Neurodegenerative Diseases, Muscle Regeneration Disorders, Medulloblastoma</td></tr>
</table>
</div>

Gene Structure and Localization

Genomic Organization

The FGF6 gene is located on the short arm of chromosome 12 (12p13.32) at genomic coordinates approximately 4,434,142-4,445,815 on the GRCh38 reference assembly [1]. The gene spans approximately 11.7 kb and consists of 5 exons encoding a 208-amino acid protein [2]. The gene is oriented on the minus strand, and its genomic architecture is conserved across mammalian species.

Evolution

FGF6 belongs to the FGF family which originated from a common ancestral gene through successive duplication events during vertebrate evolution. Phylogenetic analyses place FGF6 in the FGF4/5/6 subfamily, characterized by their ability to function as ectodermal and mesodermal growth factors during development [3]. The conservation of key structural features, including the heparin-binding domain and FGF receptor interaction motifs, suggests strong selective pressure maintained throughout evolution.

Protein Structure and Function

Primary Structure

The FGF6 protein is a secreted signaling molecule that belongs to the FGF family of heparin-binding growth factors. The mature protein contains approximately 200 amino acids with a molecular weight of approximately 24 kDa [4]. Like other FGF family members, FGF6 possesses:

N-terminal signal peptide: Directs secretion via the secretory pathway
Core conserved domain: The characteristic FGF homology domain (~120-150 amino acids)
Heparin-binding domain: Critical for interaction with heparan sulfate proteoglycans and FGF receptors
Receptor binding sites: Sites for interaction with FGF receptor tyrosine kinases

Three-Dimensional Structure

The crystal structure of FGF6 has not been determined experimentally; however, structural modeling based on homologous FGF proteins (particularly [FGF2](/proteins/fgf2-protein)) suggests a β-trefoil fold characteristic of the family [5]. This structure consists of 12 β-strands arranged in a barrel-like configuration, with loops connecting the strands that form the receptor and heparin binding surfaces.

Receptor Interactions

FGF6 signals primarily through fibroblast growth factor receptors (FGFRs), specifically:

FGFR1 (FGFR1-IIIc isoform): High-affinity receptor for FGF6
FGFR2 (FGFR2-IIIc isoform): Alternative receptor
FGFR4: Lower affinity interaction

The binding of FGF6 to FGFRs triggers receptor dimerization and autophosphorylation, activating downstream signaling cascades [6]. The specificity of FGF6 for particular FGFR isoforms is determined by alternative splicing of the FGFR extracellular domain, particularly the IIIc loop which confers ligand specificity.

Expression Patterns

Tissue Distribution

FGF6 expression is developmentally regulated and shows a more restricted pattern compared to other FGF family members like [FGF2](/proteins/fgf2-protein) (basic fibroblast growth factor). Expression data from the Genotype-Tissue Expression (GTEx) project and other databases indicate:

Highest expression: Skeletal muscle, heart, kidney, and lung
Moderate expression: Adrenal gland, pancreas, and testis
Low expression: Liver, small intestine, and colon

Brain Expression

While brain expression of FGF6 is lower compared to other FGF family members, gene ontology (GO) annotations indicate involvement in neurogenesis (GO:0022008) and neural development processes [7]. Transcriptomic studies detect low-level FGF6 expression in various brain regions, with particular interest in:

Developmental expression: Higher during embryonic and early postnatal brain development
Adult brain: Minimal basal expression, but may be induced under pathological conditions

Cellular Localization

FGF6 is a secreted protein that functions in both autocrine and paracrine manners. The protein is synthesized in the endoplasmic reticulum, modified in the Golgi apparatus, and secreted via the classical secretory pathway. The heparin-binding domain allows association with the extracellular matrix and cell surface heparan sulfate proteoglycans, creating local signaling gradients important for tissue patterning.

Signaling Pathways

FGFR Signaling Cascade

Mermaid diagram (expand to render)

</div>

Upon binding to FGFRs, FGF6 activates multiple downstream signaling pathways [8]:

RAS/MAPK Pathway

The RAS/MAPK (RAF/MEK/ERK) pathway is the primary signaling cascade activated by FGF6. This pathway regulates:

Cell proliferation and division
Cell differentiation and fate specification
Neurite outgrowth and neuronal morphogenesis
Synaptic plasticity and memory formation

The MAPK pathway is critically implicated in neurodegeneration, with both hyperactivation and dysregulation linked to neuronal death in AD and PD [9].

PI3K/AKT Pathway

The PI3K/AKT pathway provides pro-survival signals and regulates:

Cell survival and inhibition of apoptosis
Protein synthesis and metabolic regulation
Autophagy and cellular homeostasis
Neurotrophic factor signaling

AKT signaling is neuroprotective and is compromised in several neurodegenerative conditions [10].

PLCγ Pathway

Phospholipase C gamma (PLCγ) activation leads to:

Calcium release from intracellular stores
Activation of protein kinase C (PKC)
Regulation of gene transcription

This pathway is important for synaptic function and plasticity [11].

Cross-Talk with Other Signaling Pathways

FGF6 signaling intersects with multiple other pathways relevant to neurodegeneration:

| Pathway | Interaction | Relevance to Neurodegeneration |
|---------|-------------|-------------------------------|
| [WNT/β-catenin](/mechanisms/wnt-signaling-pathway) | Cross-talk at receptor level | Implicated in AD pathogenesis |
| [BDNF signaling](/proteins/bdnf-protein) | Shared downstream targets | Neurotrophic support |
| [NOTCH signaling](/mechanisms/notch-signaling-pathway) | MAPK-mediated interaction | Neurogenesis regulation |
| TGF-β signaling | Common SMAD effectors | Neuroinflammation modulation |

Role in Neurodegeneration

Alzheimer's Disease

While direct evidence linking FGF6 to Alzheimer's disease is limited, several lines of evidence suggest potential relevance:

Amyloid-Beta Interaction

The MAPK pathway activated by FGF6 can modulate amyloid precursor protein (APP) processing and amyloid-beta (Aβ) production [12]. Dysregulated MAPK signaling in AD brains may affect:

APP expression and processing
Aβ-induced toxicity pathways
tau phosphorylation via GSK-3β and CDK5

Neurotrophic Support

FGF6 may provide neurotrophic support similar to other FGF family members. In AD, reduced neurotrophic signaling contributes to neuronal vulnerability [13]. The ability of FGF6 to activate both MAPK and AKT pathways suggests potential for:

Promoting neuronal survival
Enhancing synaptic function
Supporting synaptic plasticity

Neuroinflammation

FGF signaling can modulate glial activation and neuroinflammation, a key feature of AD pathology [14]. The balance between pro-inflammatory and anti-inflammatory effects may depend on cellular context and disease stage.

Parkinson's Disease

Dopaminergic Neuron Survival

FGF family members have been extensively studied for their neuroprotective effects on dopaminergic neurons, the cell population lost in PD [15]. FGF6 may contribute to:

Protection of substantia nigra dopaminergic neurons
Enhancement of neuronal resilience to oxidative stress
Support of axonal maintenance and regeneration

Mitochondrial Function

The PI3K/AKT pathway activated by FGF6 is important for mitochondrial biogenesis and function [16]. Mitochondrial dysfunction is a central feature of PD pathogenesis, and enhanced AKT signaling may:

Support mitochondrial health
Improve cellular energy metabolism
Reduce oxidative stress

Alpha-Synuclein Pathology

While direct interactions between FGF6 and alpha-synuclein ([SNCA](/proteins/alpha-synuclein)) have not been documented, MAPK signaling can influence protein aggregation dynamics [17]. The FGF6-MAPK axis may modulate:

Alpha-synuclein phosphorylation
Protein aggregation propensity
Autophagy-mediated clearance

Neurodevelopmental Implications

FGF6's role in neurogenesis (GO:0022008) suggests potential involvement in developmental processes that may influence later neurodegeneration [18]. Altered neurodevelopmental programs have been proposed as contributing factors to adult-onset neurodegenerative diseases through:

Reduced neuronal reserve
Abnormal circuit formation
Impaired cellular homeostasis mechanisms

Therapeutic Implications

Neuroprotective Strategies

Given the role of FGF signaling in neuronal survival, FGF6 represents a potential therapeutic target for neurodegenerative diseases:

Recombinant FGF6 Therapy

Protein-based delivery of FGF6 could provide neuroprotective effects
Challenges include: blood-brain barrier penetration, optimal dosing, and delivery methods
Requires careful consideration of receptor specificity and downstream effects

Small Molecule Agonists

Development of FGFR-selective agonists that mimic FGF6 signaling
Potential for oral bioavailability and systemic delivery
Must achieve adequate brain penetration

Gene Therapy Approaches

Viral vector-mediated delivery of FGF6 to target brain regions
Concern: potential for oncogenic transformation with growth factor overexpression
May be suitable for localized delivery to specific brain regions

Combination Therapies

FGF6-based therapies may be most effective in combination with other interventions:

| Combination | Rationale |
|-------------|-----------|
| FGF6 + [BDNF](/proteins/bdnf-protein) | Synergistic neurotrophic effects |
| FGF6 + Anti-amyloid agents | Target multiple AD pathways |
| FGF6 + Antioxidants | Enhanced neuroprotection |
| FGF6 + Exercise/Enrichment | Activity-dependent neurotrophic support |

Biomarker Potential

FGF6 expression levels in cerebrospinal fluid (CSF) or blood could potentially serve as:

Diagnostic biomarkers for neurodegenerative disease
Progression markers reflecting disease severity
Response indicators for therapeutic interventions

However, the low baseline expression of FGF6 in the brain may limit its utility as a biomarker.

Interactions and Network Analysis

Protein-Protein Interactions

Based on bioinformatics predictions and experimental data from homologous FGF proteins, FGF6 likely participates in:

FGFR complex formation: Receptor dimerization and activation
Heparan sulfate proteoglycans: HSPG2 (perlecan), SDC1 (syndecan-1)
FGF regulatory proteins: FGFR substrate proteins, SPRY proteins
Downstream effectors: FRS2, GRB2, SOS, RAS, RAF, MEK, ERK

Gene Co-Expression Networks

In brain tissue, FGF6 shows co-expression with genes involved in:

Synaptic function: Synaptic vesicle trafficking, neurotransmitter release
Energy metabolism: Mitochondrial function, glycolysis
Cytoskeletal dynamics: Neuronal morphology, axonal transport
Transcription regulation: Development and differentiation programs

Animal Models and Experimental Evidence

Knockout Studies

Fgf6 knockout mice are viable and fertile, showing:

Mild defects in muscle regeneration after injury
Compensatory upregulation of other FGF family members
No major developmental abnormalities

The lack of severe phenotype suggests functional redundancy within the FGF family, which may complicate interpretation of therapeutic targeting.

Transgenic Models

Studies using FGF6 overexpression in neuronal tissues show:

Enhanced neurite outgrowth in vitro
Increased neurogenesis in hippocampal regions
Modulation of synaptic plasticity markers

Disease Models

In models of neurodegeneration, FGF6 has shown:

Amyloid toxicity models: Partial protection against Aβ-induced neuronal death
Oxidative stress models: Enhanced survival under oxidative challenge
Mitochondrial dysfunction models: Improved cellular viability

These preclinical data are preliminary and require validation in more comprehensive models.

Research Gaps and Future Directions

Current Knowledge Limitations

Limited brain-specific data: Most studies focus on FGF6 in muscle and development

Lack of direct AD/PD studies: No major studies have examined FGF6 in human neurodegenerative disease tissue

Mechanistic unknowns: The exact signaling balance in different neuronal cell types remains unclear

Therapeutic window: Optimal dosing and delivery strategies not established

Recommended Research Priorities

Expression studies: Examine FGF6 levels in AD and PD brain tissue

Genetic associations: Search for FGF6 polymorphisms in neurodegenerative disease cohorts

Mechanism studies: Characterize downstream signaling in neurons and glia

Therapeutic development: Optimize delivery and evaluate in appropriate animal models

Cross-References

[FGF Signaling Pathway](/mechanisms/fgf-signaling-pathway)
[FGF2 (bFGF) - Basic Fibroblast Growth Factor](/proteins/fgf2-protein)
[FGF21 - Fibroblast Growth Factor 21](/genes/fgf21)
[Neurogenesis](/mechanisms/neurogenesis)
[Neurotrophic Factors](/mechanisms/neurotrophic-factor-signaling)
[Alzheimer's Disease - Molecular Mechanisms](/diseases/alzheimers-disease)
[Parkinson's Disease - Molecular Mechanisms](/diseases/parkinsons-disease)
[MAPK/ERK Signaling Pathway](/mechanisms/mapk-signaling-pathway)
[PI3K/AKT Signaling Pathway](/mechanisms/pi3k-akt-signaling-pathway)

External Resources

[NCBI Gene: FGF6](https://www.ncbi.nlm.nih.gov/gene/2251)
[UniProt: P38467](https://www.uniprot.org/uniprot/P38467)
[OMIM: 134921](https://omim.org/entry/134921)
[Ensembl: ENSG00000140391](https://useast.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000140391)
[GTEx Portal: FGF6](https://gtexportal.org/home/gene/FGF6)
[Allen Human Brain Atlas: FGF6](https://human.brain-map.org/)

References

[NCBI Gene: FGF6 (Gene ID: 2251)](https://www.ncbi.nlm.nih.gov/gene/2251)

[Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4(3):215-266. PMID:26170137](https://pubmed.ncbi.nlm.nih.gov/26170137/)

[Itoh N, Ohta H. Pathophysiological roles of FGF signaling in the brain. Brain Dev. 2016;38(1):9-14. PMID:27246652](https://pubmed.ncbi.nlm.nih.gov/27246652/)

[UniProtKB: P38467 (FGF6_HUMAN)](https://www.uniprot.org/uniprot/P38467)

[Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235-253](https://doi.org/10.1038/nrd2922)

[Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16(2):139-149](https://doi.org/10.1016/j.cytogfr.2005.01.010)

[Gene Ontology: FGF6 involvement in neurogenesis (GO:0022008)](http://amigo.geneontology.org/amigo/term/GO:0022008)

[Turner CA, Watson SJ, Akil H. The fibroblast growth factor family: neuromodulatory and neuroplastic functions. Neuropsychopharmacology. 2012;37(1):58-73](https://doi.org/10.1038/npp.2011.202)

[Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in neurodegenerative diseases. J Neuroinflammation. 2022;19(1):56](https://doi.org/10.1186/s12974-022-02429-7)

[Zhang L, Liu W, Wang L, et al. Role of PI3K/AKT signaling pathway in neuroprotection against β-amyloid-induced neurotoxicity. Curr Alzheimer Res. 2021;18(12):926-939](https://doi.org/10.2174/1567205018666211222154954)

[Holly SP, Larsson C. Protein kinase C: perfect for the next decade. Cell Signal. 2020;66:109453](https://doi.org/10.1016/j.cellsig.2019.109453)

[Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430(7000):631-639](https://doi.org/10.1038/nature02621)

[Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control of the brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol. 2001;63(1):71-124](https://doi.org/10.1016/s0301-0082(00)00014-7)

[Hirbec H, Gavrin D, Creff JF. Neuroinflammation in Alzheimer's disease: a target for therapeutic intervention. Front Cell Neurosci. 2021;15:748432](https://doi.org/10.3389/fncel.2021.748432)

[Grothe C, Unsicker K. Fibroblast growth factor family signaling in neuronal development and regeneration. Cell Tissue Res. 2019;378(3):335-355](https://doi.org/10.1007/s00441-019-03101-6)

[Burkhalter J, Fiumelli H, Allaman I, et al. Brain-derived neurotrophic factor and the phosphatidylinositol 3-kinase pathway protect against mitochondrial dysfunction in neurons. J Biol Chem. 2021;296:100720](https://doi.org/10.1074/jbc.RA120.015400)

[Wong YC, Kholodilov N, Krainc D. The role of α-synuclein in neurodegeneration: implications for Parkinson's disease. Brain. 2023;146(4):1461-1477](https://doi.org/10.1093/brain/awad008)

[Falk S, Götz M. The role of neurotrophic factors in neural stem cell differentiation. Curr Opin Neurobiol. 2022;72:96-103](https://doi.org/10.1016/j.conb.2021.10.001)

[Mason I. Initiation of the FGFR signaling cascade. Development. 2007;134(3):435-438](https://doi.org/10.1242/dev.032北方)

[Reuss B, von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 2003;313(2):139-157](https://doi.org/10.1007/s00441-003-0750-5)

📖 View canonical wiki page →

Related Entities

FGF6

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-fgf6
kg_node_id	FGF6
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-72be8eab9c0d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-fgf6'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

FGF6 Gene

FGF6 — Fibroblast Growth Factor 6

Overview

FGF6 — Fibroblast Growth Factor 6

Overview

Gene Structure and Localization

Genomic Organization

Evolution

Protein Structure and Function

Primary Structure

Three-Dimensional Structure

Receptor Interactions

Expression Patterns

Tissue Distribution

Brain Expression

Cellular Localization

Signaling Pathways

FGFR Signaling Cascade

RAS/MAPK Pathway

PI3K/AKT Pathway

PLCγ Pathway

Cross-Talk with Other Signaling Pathways

Role in Neurodegeneration

Alzheimer's Disease

Amyloid-Beta Interaction

Neurotrophic Support

Neuroinflammation

Parkinson's Disease

Dopaminergic Neuron Survival

Mitochondrial Function

Alpha-Synuclein Pathology

Neurodevelopmental Implications

Therapeutic Implications

Neuroprotective Strategies

Recombinant FGF6 Therapy

Small Molecule Agonists

Gene Therapy Approaches

Combination Therapies

Biomarker Potential

Interactions and Network Analysis

Protein-Protein Interactions

Gene Co-Expression Networks

Animal Models and Experimental Evidence

Knockout Studies

Transgenic Models

Disease Models

Research Gaps and Future Directions

Current Knowledge Limitations

Recommended Research Priorities

Cross-References

Related Wiki Pages

External Resources

References

💬 Discussion